CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
Country • Select Country
    Entity • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Deutsch ελληνικά Español Français Italiano Magyar Nederlands Polski Română Русский 简体中文 繁體中文

    Trade Alibaba Health Information Technology Limited - 0241 CFD

    4.29
    1.38%
    0.06
    Low: 4.29
    High: 4.46
    Market Trading Hours* (UTC) Opens on Tuesday at 01:30

    Mon - Fri: 01:30 - 04:00 05:00 - 08:00

    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread 0.06
    Long position overnight fee

    Long position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.026116 %
    Charges from full value of position ($-4.96)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.026116%
    Short position overnight fee

    Short position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee 0.004199 %
    Charges from full value of position ($0.80)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		0.004199%
    Overnight fee time 22:00 (UTC)
    Min traded quantity 1
    Currency HKD
    Margin 5%
    Stock exchange Hong Kong
    Commission on trade 0%

    *Information provided by Capital.com

    Alibaba Health Information Technology Ltd ESG Risk Ratings

    High Medium Low Negligible

    ‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.

    More ESG coverage

    Key Stats
    Prev. Close* 4.35
    Open* 4.35
    1-Year Change* -40.41%
    Day's Range* 4.29 - 4.46
    52 wk Range 4.25-10.14
    Average Volume (10 days) 26.91M
    Average Volume (3 months) 565.03M
    Market Cap 62.66B
    P/E Ratio 107.66
    Shares Outstanding 13.53B
    Revenue 29.24B
    EPS 0.04
    Dividend (Yield %) N/A
    Beta 1.95
    Next Earnings Date N/A

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Dec 4, 2023 4.35 -0.03 -0.68% 4.38 4.49 4.31
    Dec 1, 2023 4.35 -0.08 -1.81% 4.43 4.44 4.32
    Nov 30, 2023 4.42 -0.24 -5.15% 4.66 4.66 4.37
    Nov 29, 2023 4.59 -0.31 -6.33% 4.90 4.92 4.53
    Nov 28, 2023 4.63 0.00 0.00% 4.63 4.66 4.55
    Nov 27, 2023 4.63 0.06 1.31% 4.57 4.69 4.55
    Nov 24, 2023 4.55 -0.10 -2.15% 4.65 4.65 4.54
    Nov 23, 2023 4.66 0.08 1.75% 4.58 4.67 4.56
    Nov 22, 2023 4.61 -0.05 -1.07% 4.66 4.67 4.57
    Nov 21, 2023 4.62 -0.09 -1.91% 4.71 4.83 4.61
    Nov 20, 2023 4.66 0.15 3.33% 4.51 4.69 4.51
    Nov 17, 2023 4.57 -0.16 -3.38% 4.73 4.76 4.43
    Nov 16, 2023 4.87 -0.07 -1.42% 4.94 4.95 4.81
    Nov 15, 2023 4.94 0.00 0.00% 4.94 4.98 4.87
    Nov 14, 2023 4.79 0.01 0.21% 4.78 4.83 4.76
    Nov 13, 2023 4.80 0.09 1.91% 4.71 4.81 4.66
    Nov 10, 2023 4.69 -0.01 -0.21% 4.70 4.73 4.65
    Nov 9, 2023 4.76 -0.10 -2.06% 4.86 4.94 4.74
    Nov 8, 2023 4.89 0.04 0.82% 4.85 5.02 4.82
    Nov 7, 2023 4.84 -0.04 -0.82% 4.88 5.01 4.84

    Alibaba Health Information Technology Limited Events

    Time (UTC) Country Event
    No events scheduled
    View all events
    • Annual
    • Quarterly
    2023 2022 2021 2020 2019
    Total revenue 26763 20577.6 15518.5 9596.48 5095.87
    Revenue 26763 20577.6 15518.5 9596.48 5095.87
    Cost of Revenue, Total 21061.7 16469.6 11901.2 7365.1 3764.6
    Gross Profit 5701.33 4107.99 3617.25 2231.38 1331.26
    Total Operating Expense 26217.6 20780.7 15076.4 9531.38 5127.09
    Selling/General/Admin. Expenses, Total 2161.5 2376.49 1529.68 947.106 638.17
    Research & Development 677.822 728.828 423.632 252.843 219.018
    Interest Expense (Income) - Net Operating -454.218 -415.342 -309.776 -29.33 -51.304
    Unusual Expense (Income) -60.21 -380.177 -82.196 -63.584 -12.432
    Other Operating Expenses, Total 2830.99 2001.27 1613.83 1059.25 569.031
    Operating Income 545.446 -203.079 442.081 65.091 -31.22
    Interest Income (Expense), Net Non-Operating 5.548 -49.435 -40.862 -55.997 -29.61
    Net Income Before Taxes 550.994 -252.514 401.219 9.094 -60.83
    Net Income After Taxes 534.263 -265.941 342.68 -15.696 -91.764
    Minority Interest -0.856 0.386 5.908 9.11 9.815
    Net Income Before Extra. Items 533.407 -265.555 348.588 -6.586 -81.949
    Net Income 533.407 -265.555 348.588 -6.586 -81.949
    Income Available to Common Excl. Extra. Items 533.407 -265.555 348.588 -6.586 -81.949
    Income Available to Common Incl. Extra. Items 533.407 -265.555 348.588 -6.586 -81.949
    Diluted Net Income 533.407 -265.555 348.588 -6.586 -81.949
    Diluted Weighted Average Shares 13541.6 13482.6 13326.5 11931.3 11055
    Diluted EPS Excluding Extraordinary Items 0.03939 -0.0197 0.02616 -0.00055 -0.00741
    Diluted Normalized EPS 0.03508 -0.03802 0.02095 -0.00402 -0.00814
    Mar 2023 Sep 2022 Mar 2022 Sep 2021 Mar 2021
    Total revenue 15262.4 11500.6 11219.9 9357.71 8356.44
    Revenue 15262.4 11500.6 11219.9 9357.71 8356.44
    Cost of Revenue, Total 11861.8 9199.91 8982.68 7486.94 6599.5
    Gross Profit 3400.68 2300.66 2237.22 1870.78 1756.93
    Total Operating Expense 14894 11323.6 11218.2 9562.46 8279.28
    Selling/General/Admin. Expenses, Total 1117.37 1032.62 1221.41 1158.93 881.62
    Research & Development 353.836 323.986 406.078 322.75 194.183
    Interest Expense (Income) - Net Operating -260.821 -156.512 -91.366 -548.078 -245.832
    Unusual Expense (Income) -62.356 -1.021 -357.811 -23.723 -73.517
    Other Operating Expenses, Total 1884.16 924.632 1057.25 1165.64 923.32
    Operating Income 368.494 176.952 1.661 -204.74 77.159
    Interest Income (Expense), Net Non-Operating 8.525 -2.977 -24.313 -25.122 -0.381
    Net Income Before Taxes 377.019 173.975 -22.652 -229.862 76.778
    Net Income After Taxes 372.287 161.976 -34.373 -231.568 64.126
    Minority Interest 0.459 -1.315 0.589 -0.203 1.031
    Net Income Before Extra. Items 372.746 160.661 -33.784 -231.771 65.157
    Net Income 372.746 160.661 -33.784 -231.771 65.157
    Income Available to Common Excl. Extra. Items 372.746 160.661 -33.784 -231.771 65.157
    Income Available to Common Incl. Extra. Items 372.746 160.661 -33.784 -231.771 65.157
    Diluted Net Income 372.746 160.661 -33.784 -231.771 65.157
    Diluted Weighted Average Shares 13562.1 13521.1 13487.3 13477.9 13614.8
    Diluted EPS Excluding Extraordinary Items 0.02748 0.01188 -0.0025 -0.0172 0.00479
    Diluted Normalized EPS 0.02294 0.01181 -0.01975 -0.01834 0.00028
    Dividends per Share - Common Stock Primary Issue 0 0
    • Annual
    • Quarterly
    2023 2022 2021 2020 2019
    Total Current Assets 14913.8 13565.5 14199.7 5013 3303.39
    Cash and Short Term Investments 10917.2 10547.9 11636.8 2997.47 2017.08
    Cash 8941.31 8325.42 6419.69 2033.26
    Cash & Equivalents 280.371
    Short Term Investments 1975.86 2222.43 5217.08 964.204 1736.71
    Total Receivables, Net 1279.34 1073.94 772.908 589.166 538.798
    Accounts Receivable - Trade, Net 578.787 515.985 313.615 324.541 365.446
    Total Inventory 2102.31 1550.15 1468.61 1217.26 595.793
    Prepaid Expenses 464.7 330.447 310.423 148.867 150
    Other Current Assets, Total 150.262 63.125 11.017 60.239 1.719
    Total Assets 20747.6 19202 17739.2 7869.97 5981.88
    Property/Plant/Equipment, Total - Net 68.548 165.106 52.289 72.332 8.886
    Property/Plant/Equipment, Total - Gross 150.854 245.073 133.548 149.506 76.836
    Accumulated Depreciation, Total -82.306 -79.967 -81.259 -77.174 -67.95
    Goodwill, Net 810.853 810.853 54.576 54.576 27.006
    Long Term Investments 4591.5 4303.86 3420.15 2703.87 2603.23
    Note Receivable - Long Term 20.024 13.03 9.524 21.732 39.372
    Other Long Term Assets, Total 33.831 17.39
    Total Current Liabilities 5437.44 4822.13 3400.87 2609.9 3233.38
    Accounts Payable 3714.05 3528.6 2551.55 1865.53 902.651
    Accrued Expenses 176.064 169.815 105.73 59.645 56.518
    Notes Payable/Short Term Debt 0 0 0 0 1700
    Other Current Liabilities, Total 1509.9 1073.06 723.258 652.702 574.213
    Total Liabilities 5573.85 5103.55 3437.25 2600.83 3187.37
    Total Long Term Debt 40.361 84.758 17.406 37.725 0
    Long Term Debt 0
    Deferred Income Tax 122.417 116.483 39.322 19.829 11.677
    Minority Interest -26.374 -26.187 -20.346 -66.63 -57.693
    Total Equity 15173.7 14098.4 14302 5269.15 2794.52
    Common Stock 119.133 119.102 118.859 106.108 102.898
    Additional Paid-In Capital 43734.1 43499.9 43281.3 22344.7 20044.2
    Retained Earnings (Accumulated Deficit) -28706 -29261.2 -29031.4 -17571.6 -17635.3
    Treasury Stock - Common -70.482 -23.516 -22.265 -13.039 -25.052
    ESOP Debt Guarantee 477.237 460.077 363.949 210.73 231.955
    Other Equity, Total -380.919 -724.479 -452.462 150.697 75.873
    Total Liabilities & Shareholders’ Equity 20747.6 19202 17739.2 7869.97 5981.88
    Total Common Shares Outstanding 13521.4 13505.2 13475.4 12061.6 11698.3
    Intangibles, Net 309.01 326.215 2.935 4.467
    Current Port. of LT Debt/Capital Leases 37.437 50.656 20.334 32.03
    Capital Lease Obligations 40.361 84.758 17.406 37.725
    Unrealized Gain (Loss) 0.613 28.529 43.971 41.545
    Other Liabilities, Total 0 106.363
    Mar 2023 Sep 2022 Mar 2022 Sep 2021 Mar 2021
    Total Current Assets 14913.8 14575.7 13565.5 14626.1 14199.7
    Cash and Short Term Investments 10917.2 11255 10547.9 11283.1 11636.8
    Cash & Equivalents 10917.2 11255 10547.9 11256.5 11636.8
    Short Term Investments 26.68 0
    Total Receivables, Net 578.787 533.094 515.985 505.028 313.615
    Accounts Receivable - Trade, Net 578.787 533.094 515.985 505.028 313.615
    Total Inventory 2102.31 1608.81 1550.15 1759.7 1468.61
    Prepaid Expenses 1165.26 1074.65 888.4 1074.74 769.716
    Other Current Assets, Total 150.262 104.12 63.125 3.541 11.017
    Total Assets 20747.6 20322.5 19202 19658.2 17739.2
    Property/Plant/Equipment, Total - Net 68.548 79.463 165.106 93.769 52.289
    Goodwill, Net 810.853 810.853 810.853 845.305 54.576
    Intangibles, Net 309.01 317.125 326.215 335.526 2.935
    Long Term Investments 4591.5 4499.12 4303.86 3747.42 3420.15
    Note Receivable - Long Term 20.024 24.215 13.03 10.07 9.524
    Total Current Liabilities 5437.44 5229.32 4822.13 5352.25 3400.87
    Accounts Payable 3714.05 3750.4 3528.6 4233.63 2551.55
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 37.437 36.045 50.656 25.423 20.334
    Other Current Liabilities, Total 1685.96 1442.88 1242.88 1093.2 828.988
    Total Liabilities 5573.85 5378.2 5103.55 5584.21 3437.25
    Total Long Term Debt 40.361 52.188 84.758 42.404 17.406
    Capital Lease Obligations 40.361 52.188 84.758 42.404 17.406
    Deferred Income Tax 122.417 116.107 116.483 114.226 39.322
    Minority Interest -26.374 -25.838 -26.187 -25.564 -20.346
    Total Equity 15173.7 14944.3 14098.4 14074 14302
    Common Stock 119.133 119.122 119.102 118.875 118.859
    Additional Paid-In Capital 43734.1 43674.9 43499.9 43399.4 43281.3
    Retained Earnings (Accumulated Deficit) -28706 -29093 -29261.2 -29254.8 -29031.4
    Treasury Stock - Common -70.482 -11.549 -23.516 -32.596 -22.265
    ESOP Debt Guarantee 477.237 416.542 460.077 419.61 363.949
    Unrealized Gain (Loss) 0.613 9.688 28.529 44.228 43.971
    Other Equity, Total -380.919 -171.453 -724.479 -620.675 -452.462
    Total Liabilities & Shareholders’ Equity 20747.6 20322.5 19202 19658.2 17739.2
    Total Common Shares Outstanding 13521.4 13520.1 13505.2 13477.3 13475.4
    Other Liabilities, Total 0 6.424 106.363 100.887
    Other Long Term Assets, Total 33.831 16.013 17.39
    • Annual
    • Quarterly
    2023 2022 2021 2020 2019
    Net income/Starting Line -252.514 401.219 9.094 -60.83
    Cash From Operating Activities 255.69 424.363 1009.43 583.615 396.37
    Cash From Operating Activities 48.671 31.062 33.125 3.989
    Non-Cash Items -247.119 178.196 265.003 168.324
    Cash Taxes Paid 45.336 27.897 8.535 19.264
    Cash Interest Paid 3.815 2.449 39.294 10.624
    Changes in Working Capital 255.69 863.42 396.937 274.916 284.887
    Cash From Investing Activities -532.436 1872.31 -4961.48 1345.39 -2395.71
    Capital Expenditures -15.115 -17.558 -13.511 -6.102
    Other Investing Cash Flow Items, Total -532.436 1887.42 -4943.93 1358.9 -2389.61
    Cash From Financing Activities -111.278 -58.628 8922.41 328.814 1708.49
    Financing Cash Flow Items -111.278 -4.79 -0.11 -36.161 -10.624
    Issuance (Retirement) of Stock, Net -6.826 8954.13 2094.75 19.113
    Issuance (Retirement) of Debt, Net -47.012 -31.616 -1729.77 1700
    Foreign Exchange Effects 283.447 -148.891 -313.057 56.796 62.804
    Net Change in Cash -104.577 2089.15 4657.29 2314.61 -228.048
    Amortization 11.905 2.013 1.477
    Mar 2023 Sep 2022 Mar 2022 Sep 2021 Mar 2021
    Net income/Starting Line 173.975 -252.514 -229.862 401.219
    Cash From Operating Activities 255.69 504.049 424.363 597.704 1009.43
    Cash From Operating Activities 26.783 48.671 20.594 31.062
    Amortization 9.114 11.905 2.465 2.013
    Non-Cash Items 106.416 -247.119 -114.38 178.196
    Cash Taxes Paid 18.507 45.336 40.699 27.897
    Cash Interest Paid 3.362 3.815 0.737 2.449
    Changes in Working Capital 255.69 187.761 863.42 918.887 396.937
    Cash From Investing Activities -532.436 -736.551 1872.31 1341.08 -4961.48
    Capital Expenditures -4.777 -15.115 -6.834 -17.558
    Other Investing Cash Flow Items, Total -532.436 -731.774 1887.42 1347.91 -4943.93
    Cash From Financing Activities -111.278 -16.01 -58.628 -20.816 8922.41
    Financing Cash Flow Items -111.278 0 -4.79 -4.79 -0.11
    Issuance (Retirement) of Stock, Net 8.185 -6.826 6.2 8954.13
    Issuance (Retirement) of Debt, Net -24.195 -47.012 -22.226 -31.616
    Foreign Exchange Effects 283.447 309.91 -148.891 -123.909 -313.057
    Net Change in Cash -104.577 61.398 2089.15 1794.06 4657.29
    Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
    Alibaba Group Holding Ltd. Corporation 34.0604 4609501872 0 2023-08-30 LOW
    Perfect Advance Holding Ltd. Corporation 22.9346 3103816661 0 2023-08-30 LOW
    21CN Corporation Corporation 5.745 777484030 0 2023-03-31 LOW
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 1.383 187164182 626000 2023-09-30 LOW
    Krane Funds Advisors, LLC Investment Advisor 1.2999 175922000 -156000 2023-09-30 LOW
    BlackRock Institutional Trust Company, N.A. Investment Advisor 0.8611 116533678 514000 2023-09-30 LOW
    China Asset Management Co., Ltd. Investment Advisor 0.5353 72437638 -2355488 2023-09-30 LOW
    Bosera Asset Management Co., Ltd. Investment Advisor 0.5048 68318000 23196000 2023-06-30 MED
    CSOP Asset Management Limited Investment Advisor 0.4801 64979382 111002 2023-09-30 HIGH
    Fullgoal Fund Management Co., Ltd. Investment Advisor/Hedge Fund 0.453 61300000 34216000 2023-06-30 MED
    State Street Global Advisors Asia Ltd. Investment Advisor/Hedge Fund 0.4488 60733868 1984348 2023-09-30 LOW
    Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 0.445 60227998 -3438950 2022-12-31 LOW
    BlackRock Advisors (UK) Limited Investment Advisor/Hedge Fund 0.3589 48574033 370000 2023-09-30 LOW
    E Fund Management Co. Ltd. Investment Advisor 0.3493 47266168 236000 2023-06-30 LOW
    Bank of Communications Schroder Fund Management Co., Ltd. Investment Advisor 0.3005 40674000 -4040000 2023-06-30 MED
    UBS Asset Management (Hong Kong) Limited Investment Advisor 0.2785 37690000 0 2023-06-30 LOW
    BlackRock (Singapore) Limited Investment Advisor 0.2677 36230877 -1820253 2023-09-30 HIGH
    Hang Seng Investment Management Ltd. Investment Advisor 0.206 27878099 2640 2023-09-30 LOW
    Candriam Luxembourg S.A. Investment Advisor 0.2025 27399000 0 2023-09-30 MED
    Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.1506 20377000 -18000 2023-09-30 LOW

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)
    Profit/Loss

    For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

    Alibaba Health Company profile

    Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical e-commerce, intelligent medicine, and product tracking platform businesses in the People's Republic of China. The company engages in the B2C pharmacy business that provides outsourced and value-added services, and other related services to the Tmall entities, and centralized procurement and distribution businesses. It also operates Drug PIATS, a product identification, authentication, and tracking system for the drug industry; and a medical services network, as well as offers online health consultation services. The company was formerly known as CITIC 21CN Company Limited and changed its name to Alibaba Health Information Technology Limited in September 2014. It has strategic collaboration agreement with Merck KGaA to develop patient-centric digital services. The company is based in Causeway Bay, Hong Kong. Alibaba Health Information Technology Limited is a subsidiary of Perfect Advance Holding Limited.
    Industry: Internet & Mail Order Department Stores

    銅鑼灣勿地臣街1號時代廣場1座26樓
    HK

    Income Statement

    • Annual
    • Quarterly

    News

    December RBA preview: no move expected at the final meeting of 2023

    The RBA meets on Tuesday, 5th of December, 2023, at 2.30 PM (AEDT). We preview what to expect from this month’s decision.

    14:47, 4 December 2023

    CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

    CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

    12:39, 30 November 2023

    Euro Zone CPI expected to continue dropping; economists warn about cutting too soon

    EZ PI expected to drop further but speed of decline

    08:16, 29 November 2023

    A weaker Dollar drives gold higher

    Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.

    13:49, 28 November 2023

    Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain

    US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.

    13:20, 28 November 2023

    RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023

    The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.

    13:04, 28 November 2023

    Crude prices slide on OPEC+ uncertainty

    Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.

    12:55, 28 November 2023

    People also watch

    US100

    15,828.90 Price
    -1.080% 1D Chg, %
    Long position overnight fee -0.0262%
    Short position overnight fee 0.0040%
    Overnight fee time 22:00 (UTC)
    Spread 7.0

    Oil - Crude

    73.45 Price
    -1.400% 1D Chg, %
    Long position overnight fee -0.0200%
    Short position overnight fee -0.0019%
    Overnight fee time 22:00 (UTC)
    Spread 0.030

    XRP/USD

    0.63 Price
    +0.150% 1D Chg, %
    Long position overnight fee -0.0753%
    Short position overnight fee 0.0069%
    Overnight fee time 22:00 (UTC)
    Spread 0.01168

    BTC/USD

    42,203.90 Price
    +5.790% 1D Chg, %
    Long position overnight fee -0.0616%
    Short position overnight fee 0.0137%
    Overnight fee time 22:00 (UTC)
    Spread 106.00

    Still looking for a broker you can trust?

    Join the 570.000+ traders worldwide that chose to trade with Capital.com

    1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading